Atlas Trials

Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia

Clinical trial NCT02589340 · TERMINATED

Trial details

NCT number
NCT02589340
Sponsor
Oregon Health and Science University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's DiseaseDyskinesiasMovement Disorders
Start date
2016-01-01
Primary completion
2021-02-23
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.